Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.

Slides:



Advertisements
Similar presentations
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
Advertisements

Tips to a Successful Monitoring Visit
Chicken Soup for the Busy Coordinator
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
Why bother? Trying to do something differently in an academic or NHS setting can sometimes be a frustrating experience.
Monitoring and Auditing
Practical Effective Steps to Improve Trial QUALITY from Audit/Inspections findings Cancer Clinical Trials Unit Scotland A NCRI Accredited Cancer Trials.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
Laura Cocking Senior Data Manager Peninsula Clinical Trials Unit A Trial Manager’s Guide to Data Management Exeter Clinical Trials Support Network Event.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Tool Summary Sheet Note: This hidden slide will not show in a slide presentation. Remove before providing slide deck to sites. Tool: Sponsor Responsibilities.
Monitoring and Special Considerations for Multi-Center Trials
Protocol Complexity as a Factor in Vendor Management Compliance Risk
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Research and Development Protocol Submission and Continuing Review Processes Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas.
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Janet Ellen Holwell, CCRC, CCRA President, NY Metropolitan Chapter of ACRP.
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Planning and Surviving An Audit/Monitoring visit Carmen B. Jacobs, BS, RN,OCN, CCRP U.T. MD Anderson Cancer Center Houston, Texas U.S.A.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Data Management in Clinical Trials. E-CRF design / P-CRF Data entryData validation Data import Clinical coding DATABASE CLOSURE Database Closure Documents.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
ANJALI JADHAV ANKITA SINGH ANUJA AHIRE ANURADHA PRASAD BEVIN D’SOUZA.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Boehringer Ingelheim Investigator Meeting Study POLO- AML-2 February 23, 2013/Toronto Behbood Sadrolhefazi Therapeutic Area Specialist/ Oncology.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
24 Nov 2007Data Management and Exploratory Data Analysis 1 Yongyuth Chaiyapong Ph.D. (Mathematical Statistics) Department of Statistics Faculty of Science.
Good Clinical Practice (GCP) UKTMN 6 th June 2006.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
Surviving CTIMPs and MHRA inspections Kim Gooding Diabetes and Vascular Medicine UEMS and Exeter CRF Exeter Clinical Research Facility.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Supervisory Responsibilities of Clinical Investigators
Good Clinical Practice (GCP) and Monitoring Practices
The Role and Responsibilities of the Clinical Research Coordinator
Responsibilities of Sponsor, Investigator and Monitor
MAINTAINING THE INVESTIGATOR’S SITE FILE
Administering Informed Consent Issues for Discussion
Good Clinical Practice (GCP) requirements for ANODE
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
Regulatory Binder: Maintaining Essential Study Documentation
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Quality Control SOP 3.12 Release Date: 08/10/2015.
Gilbert Ogetii KEMRI-Wellcome Trust Research Programme Kilifi, Kenya
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Monitoring, Auditing and Compliance
Code of Ethics for CDM Professionals
Code of Ethics for CDM Professionals
A Clinical Data Analyst with SAS Programming
Good clinical practice
Presentation transcript:

Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager

Joint Research & Enterprise Office Training CI and PIs Monitor Regulatory Assurance Manager Stats. ?RN/CTA/DM Research Pharmacy Archivist Finance Support Departments IT - eCRF The Team

Joint Research & Enterprise Office Training Lots of meetings! Site selection Risk Assessment (26 point risk assessment) Major issues identified and minimised Monitoring plan – agreed with all parties even if external monitor Standard RG processes – initiation, routine, close out Safety reporting How are the studies set up?

Joint Research & Enterprise Office Training Sponsor

Joint Research & Enterprise Office Training Sponsor Sponsor takes on overall responsibility for initiation, management and/or financing of study All clinical trials must have a designated sponsor –Must be named in the protocol Not necessarily the funder –Typically CI employer Can delegate responsibilities to investigators

Joint Research & Enterprise Office Training Quality Assurance (audits) Quality Control (monitoring) Contracts & Agreements Medical Expertise Trial Design Trial Management, Data Handling, and Record Keeping Investigator Selection Allocation of Responsibilities Compensation to Subjects and Investigators Financing Submission to Regulatory Authorities Confirmation of Review by REC Information on IMP Manufacturing, Packaging, Labelling, and Coding of IMP Supplying and Handling of IMP Record Access Safety Information Safety Reporting Non-compliance Premature Termination or Suspension of a Trial Clinical Trial/Study Reports Multi-centre Trials ICH GCP Section 5 Joint Research & Enterprise Office Training Sponsor Responsibilities

Joint Research & Enterprise Office Training Quality Assurance (QA) versus Quality Control (QC) QC = Quality Control = monitoring –Member of trial team –Ongoing QA = Quality Assurance = auditing –Independent –Planned and systematic Joint Research & Enterprise Office Training

Monitoring Joint Research & Enterprise Office Training

What is monitoring? Joint Research & Enterprise Office Training “The act of overseeing the progress of a clinical trial, and of ensuring that it is conducted, recorded, and reported in accordance with the protocol, SOPs, GCP, and any regulatory requirements” ICH GCP Section 5.18 Joint Research & Enterprise Office Training

Purpose of Monitoring? Joint Research & Enterprise Office Training Protection of rights and wellbeing of human participants –Ensure consent in place for record access Trial data are accurate, complete and verifiable from source documents Conduct of trial is in compliance with the currently approved protocol, GCP, and all applicable regulatory requirements ICH GCP Section Joint Research & Enterprise Office Training

Qualities of a Good Monitor? Appropriately trained Adequate scientific and/or clinical knowledge –Documented with training logs and CVs Thoroughly familiar with: –IMP –Protocol –Consent form –Sponsor & trial SOPs –GCP Knowledge of local laws, regulations, customs & local language ICH GCP Section Joint Research & Enterprise Office Training

Extent and Nature of monitoring Monitoring should be proportionate to: –Objective –Purpose –Design –Blinding –Size and complexity –Outcome measures –Risks ICH GCP Section Joint Research & Enterprise Office Training

Types Of Monitoring (1) Coordinating centre / day-to-day monitoring –Data collected are consistent with protocol –CRFs are being completed by authorised staff –No key data is missing –Data appears to be valid –Review of recruitment rate, withdrawals and losses to f/up Joint Research & Enterprise Office Training

Types Of Monitoring (2) Central monitoring –Determination of key eligibility criteria through collection of: Consent forms (with agreement by participant) Scans Pathology reports –Statistics Unusual patterns of data Joint Research & Enterprise Office Training

Types Of Monitoring (3) On-site monitoring –Staff training –Access to necessary documents –Confirm pharmacy and lab resources in place Count study drugs –Adherence to protocol and GCP –Check medical records Consent forms Eligibility SAEs, SADRs, SUSARs etc –Source Data Verification (SDV) Joint Research & Enterprise Office Training

CRF Completion Data Entry Data cleaning & Validation Data entry checks Double data entry Post entry checks Monitoring visits & SDV Training Investigators OCR Data Management & Processing EDC system Joint Research & Enterprise Office Training

Common queries and checks Joint Research & Enterprise Office Training Most common checks to identify discrepancies: –Missing values –Range checks, including lab values and normals –Logical date sequence –Header information consistent –Missing visits or pages –Visits in compliance with protocol –Inclusion/exclusion criteria met –Procedures performed in proper order –Fraud Joint Research & Enterprise Office Training

Post 1. Data manager cleans & validates database 2. Problems such as missing values or inconsistencies 3.Queries addressed to the PI via paper query forms 4. PI resolves queries 5. Query resolutions put on query form 6. Monitor checks query resolutions 7. Query forms with resolution sent back to data manager 8. Corrections entered in database Data validated No Yes Joint Research & Enterprise Office Training Post Entry Checks Joint Research & Enterprise Office Training

Plan DoCheck Review MONITORING & AUDITS Ensuring the Quality of the Data Joint Research & Enterprise Office Training